11.61
price down icon7.64%   -0.96
after-market After Hours: 11.50 -0.11 -0.95%
loading
Traws Pharma Inc stock is traded at $11.61, with a volume of 666.80K. It is down -7.64% in the last 24 hours and up +160.05% over the past month. Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
See More
Previous Close:
$12.57
Open:
$11.01
24h Volume:
666.80K
Relative Volume:
1.48
Market Cap:
$35.13M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+128.94%
1M Performance:
+160.05%
6M Performance:
+2.97%
1Y Performance:
+0.00%
1-Day Range:
Value
$9.71
$12.25
1-Week Range:
Value
$5.00
$19.44
52-Week Range:
Value
$4.06
$19.44

Traws Pharma Inc Stock (TRAW) Company Profile

Name
Name
Traws Pharma Inc
Name
Phone
267-759-3680
Name
Address
12 PENNS TRAIL, NEWTOWN
Name
Employee
17
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
TRAW's Discussions on Twitter

Compare TRAW with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TRAW
Traws Pharma Inc
11.61 35.13M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.18 105.12B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
714.47 78.51B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
629.99 37.67B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
243.25 31.37B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
114.13 27.36B 3.30B -501.07M 1.03B -2.1146

Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-01-22 Initiated Ladenburg Thalmann Buy
May-18-21 Initiated Guggenheim Buy
Mar-01-18 Reiterated H.C. Wainwright Buy
Jan-17-18 Downgrade Maxim Group Buy → Hold
Oct-09-17 Initiated H.C. Wainwright Buy
Apr-27-17 Initiated Laidlaw Buy
Jul-01-15 Upgrade Piper Jaffray Neutral → Overweight
May-05-15 Initiated H.C. Wainwright Buy
View All

Traws Pharma Inc Stock (TRAW) Latest News

pulisher
Dec 23, 2024

Traws Pharma, Inc. Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu - Marketscreener.com

Dec 23, 2024
pulisher
Dec 23, 2024

Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November - Benzinga

Dec 23, 2024
pulisher
Dec 23, 2024

Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results - Benzinga

Dec 23, 2024
pulisher
Dec 23, 2024

Stock market news: Direct Digital Holdings +405.45%, Reliance Global Group +214.17% among top gainers during mid day trading - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

Stock market news: Direct Digital Holdings up by 363.64% while iLearningEngines down by 70.88% during mid day trading - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

Traws Pharma Stock Hits 6-Month Highs On Bird Flu Treatment Breakthrough, Retail Interest Soars - Asianet Newsable

Dec 23, 2024
pulisher
Dec 23, 2024

Key pre-market developments in biotech & aerospace - RagingBull

Dec 23, 2024
pulisher
Dec 23, 2024

Stock market today: Traws Pharma +231.47%, Rumble +59.02% among top gainers in early trading - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

US Stocks Mixed, Dow Tumbles 150 Points - Benzinga

Dec 23, 2024
pulisher
Dec 23, 2024

Stock market today: iLearningEngines plunges by 60.44% while Reliance Global Group surged by 231.67% in early trading session - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment - MarketWatch

Dec 23, 2024
pulisher
Dec 23, 2024

Traws Pharma advances bird flu treatment candidate - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

Traws Pharma's Bird Flu Drug Shows Breakthrough Results in Phase 1 Trial, Achieves 23-Day Protection - StockTitan

Dec 23, 2024
pulisher
Dec 23, 2024

The Most Therapeutic Kind of Me-Time - 69News WFMZ-TV

Dec 23, 2024
pulisher
Dec 22, 2024

Traws Pharma announces board member departure By Investing.com - Investing.com Australia

Dec 22, 2024
pulisher
Dec 22, 2024

Traws Pharma announces board member departure - Investing.com

Dec 22, 2024
pulisher
Dec 20, 2024

Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says - 69News WFMZ-TV

Dec 20, 2024
pulisher
Dec 20, 2024

More of America's Pets Are Overdosing on Stray Coke, Meth - 69News WFMZ-TV

Dec 20, 2024
pulisher
Dec 16, 2024

Trinity Capital Commits $50M to Form Energy's Revolutionary Iron-Air Battery Manufacturing - StockTitan

Dec 16, 2024
pulisher
Dec 14, 2024

Full Stock Market News from 2024-12-14 - StockTitan

Dec 14, 2024
pulisher
Nov 23, 2024

Traws Pharma faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada

Nov 23, 2024
pulisher
Nov 23, 2024

Traws Pharma faces Nasdaq delisting over equity shortfall - Investing.com

Nov 23, 2024
pulisher
Nov 21, 2024

Onconova Therapeutics stock hits 52-week low at $4.37 - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

Traws Pharma Faces Uncertain Future Amid Complex Onconova Merger - MSN

Nov 21, 2024
pulisher
Nov 21, 2024

Onconova Therapeutics stock hits 52-week low at $4.37 By Investing.com - Investing.com Australia

Nov 21, 2024
pulisher
Nov 20, 2024

Onconova Therapeutics, Inc. Announces Management Changes - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

Traws Pharma Reports Q3 Financials and Updates on Clinical Advances - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Traws Pharma (FRA:0T20) 3-Year EPS without NRI Growth Rate : 25.30% (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 16, 2024

Traws Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 16, 2024
pulisher
Nov 15, 2024

Traws Pharma Inc (TRAW) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Traws Pharma Reports Promising Antiviral Drug Progress - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Traws Pharma earnings missed by $8.56, revenue topped estimates - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Traws Pharma Reports Promising Phase 1 Data Despite Widening Q3 Losses | TRAW Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 08, 2024

Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update - Marketscreener.com

Nov 08, 2024
pulisher
Nov 01, 2024

Traws Pharma regains Nasdaq compliance with bid price - Investing.com India

Nov 01, 2024
pulisher
Nov 01, 2024

Traws Pharma regains Nasdaq compliance with bid price By Investing.com - Investing.com UK

Nov 01, 2024
pulisher
Oct 10, 2024

Expert Systems Celebrates Milestone in Clinical Development of Tivoxavir Marboxil, Potential One-Time Influenza Treatment - StockTitan

Oct 10, 2024
pulisher
Oct 09, 2024

Traws Pharma Inc (TRAW) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges Amid ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Traws Pharma Reports Positive Phase 1 Results for Influenza Therapy Tivoxavir Marboxil - MyChesCo

Oct 09, 2024
pulisher
Oct 08, 2024

Onconova Therapeutics stock hits 52-week low at $4.87 - Investing.com India

Oct 08, 2024
pulisher
Oct 08, 2024

Traws Pharma reports positive Phase 1 flu drug results - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Traws Pharma reports positive Phase 1 flu drug results By Investing.com - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Traws Pharma announces topline Phase 1 data for tivoxavir marboxil - TipRanks

Oct 08, 2024
pulisher
Oct 08, 2024

Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil - GlobeNewswire

Oct 08, 2024
pulisher
Oct 08, 2024

Traws Pharma, Inc. Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil - Marketscreener.com

Oct 08, 2024
pulisher
Oct 07, 2024

Onconova Therapeutics stock hits 52-week low at $4.87 By Investing.com - Investing.com Australia

Oct 07, 2024

Traws Pharma Inc Stock (TRAW) Financials Data

There is no financial data for Traws Pharma Inc (TRAW). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$69.91
price up icon 0.10%
$19.00
price up icon 1.77%
$40.27
price up icon 1.72%
$360.87
price down icon 0.76%
$181.62
price up icon 2.21%
$114.13
price up icon 0.55%
Cap:     |  Volume (24h):